Predicting Compound Selectivity by Self‐Organizing Maps: Cross‐Activities of Metabotropic Glutamate Receptor Antagonists
暂无分享,去创建一个
G. Schneider | Tobias Noeske | B. C. Sasse | H. Stark | C. Parsons | T. Weil | B. Sasse
[1] Burton S. Rosner,et al. Neuropharmacology , 1958, Nature.
[2] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[3] T. Kohonen. Self-organized formation of topographically correct feature maps , 1982 .
[4] T. Biden,et al. Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line. , 1992, Molecular Endocrinology.
[5] M. Martres,et al. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. , 1992, European journal of pharmacology.
[6] Johann Gasteiger,et al. The comparison of geometric and electronic properties of molecular surfaces by neural networks: Application to the analysis of corticosteroid-binding globulin activity of steroids , 1996, J. Comput. Aided Mol. Des..
[7] R. Leurs,et al. Regulation of the human histamine H1 receptor stably expressed in Chinese hamster ovary cells , 1996, British journal of pharmacology.
[8] G Schneider,et al. Artificial neural networks for computer-based molecular design. , 1998, Progress in biophysics and molecular biology.
[9] Schmid,et al. "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.
[10] Johann Gasteiger,et al. Neural networks in chemistry and drug design , 1999 .
[11] Roland Heckendorn,et al. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist , 1999, Neuropharmacology.
[12] Gisbert Schneider,et al. „Grundgerüstwechsel”︁ (Scaffold‐Hopping) durch topologische Pharmakophorsuche: ein Beitrag zum virtuellen Screening , 1999 .
[13] Jaroslaw Polanski,et al. The Comparative Molecular Surface Analysis (COMSA): A Novel Tool for Molecular Design , 2000, Comput. Chem..
[14] Mark Washburn,et al. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. , 2003, Journal of medicinal chemistry.
[15] Petra Schneider,et al. Comparison of correlation vector methods for ligand-based similarity searching , 2003, J. Comput. Aided Mol. Des..
[16] Gisbert Schneider,et al. Collection of bioactive reference compounds for focused library design , 2003 .
[17] Gisbert Schneider,et al. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps. , 2003, Journal of combinatorial chemistry.
[18] Johann Gasteiger,et al. Mining High-Throughput Screening Data of Combinatorial Libraries: Development of a Filter to Distinguish Hits from Nonhits , 2004, J. Chem. Inf. Model..
[19] Teuvo Kohonen,et al. Self-organized formation of topologically correct feature maps , 2004, Biological Cybernetics.
[20] Ersin Bayram,et al. Supervised Self-Organizing Maps in Drug Discovery. 1. Robust Behavior with Overdetermined Data Sets , 2005, J. Chem. Inf. Model..
[21] Gisbert Schneider,et al. Navigation in Chemical Space: Ligand‐Based Design of Focused Compound Libraries , 2005 .
[23] R. Wouters,et al. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists. , 2005, Journal of medicinal chemistry.
[24] H Kubinyi,et al. Chemogenomics in drug discovery. , 2006, Ernst Schering Research Foundation workshop.
[25] Tobias Noeske,et al. Allosteric Modulation of Family 3 GPCRs , 2006 .